TAIPEI, March 18, 2025 /PRNewswire/ -- TaiMed Biologics (4147 TWO), an innovation-driven biotech company, has Phase 2a ...

During the discussions, Dr. Jitendra Singh emphasized that international collaboration in research and innovation is ...

A St. Louis-based company known for its work in Alzheimer's and neurological testing can expand its footprint, thanks to a ...

It's hard watching a former local darling get restructured, but federal funding blocks and a lack of local investors are more front-of-mind.

伦敦讯 - Schroders Capital Global Innovation Trust plc今日宣布将其投资组合公司Araris Biotech AG出售给大鵬药品株式会社（Taiho Pharmaceutical Co. Ltd）。这家以创新抗体药物偶联物（ADCs）闻名的瑞士生物科技公司，交易金额包括4亿美元的预付现金，外加最高可达7.4亿美元的里程碑付款。

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

The stock market is a dynamic landscape constantly shaped by economic trends, technological advancements, and shifting ...

Staff and funding cuts to the NIH, FDA and USAID could have downstream implications for R&D in the pharma industry, experts ...

Offering free solutions can generate goodwill and strengthen relationships with both existing and potential customers. When a ...

Psychiatry was once big business for pharma, with drugs like Prozac making billions. Now a few breakthroughs are reviving ...

Cancer continues to be a leading cause of mortality worldwide, highlighting the urgent need to develop more advanced, efficient, and early detection methods.